BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17489938)

  • 1. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis.
    Saadatnia M; Tajmirriahi M
    Acta Neurol Scand; 2007 May; 115(5):295-300. PubMed ID: 17489938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
    Jick SS; Jick H
    Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.
    Martinelli I; Taioli E; Battaglioli T; Podda GM; Passamonti SM; Pedotti P; Mannucci PM
    Arch Intern Med; 2003 Dec 8-22; 163(22):2771-4. PubMed ID: 14662632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence of clotting disorders in a series of cases of thrombosis of the cerebral venous sinuses].
    González-Hernández A; Fabre-Pi O; López-Fernández JC; Araña-Toledo V; López-Veloso C; Suárez-Muñoz J
    Rev Neurol; 2007 Dec 1-15; 45(11):661-4. PubMed ID: 18050097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
    Bauersachs R; Kuhl H; Lindhoff-Last E; Ehrly AM
    Vasa; 1996; 25(3):209-20. PubMed ID: 8967151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.
    Wysokinska EM; Wysokinski WE; Brown RD; Karnicki K; Gosk-Beirska I; Grill D; McBane RD
    Neurology; 2008 Feb; 70(8):627-33. PubMed ID: 18285537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
    Mills A; Wilkinson C; Fotherby K
    Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and inherited thrombophilia: a gene-environment interaction with a risk of venous thrombosis?
    Mac Gillavry MR; Prins MH
    Semin Thromb Hemost; 2003 Apr; 29(2):219-26. PubMed ID: 12709926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraception and thrombophilia.
    Blickstein D; Blickstein I
    Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update thrombophilia].
    Lindhoff-Last E; Luxembourg B; Pabinger I
    Hamostaseologie; 2008 Dec; 28(5):365-75. PubMed ID: 19132167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hormonal changes in women on hemostasis].
    Malý J; Dulícek P
    Vnitr Lek; 2002 Dec; 48(12):1169-73. PubMed ID: 12642936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genomic diagnosis of thrombophilia in women: clinical relevance].
    Luxembourg B; Lindhoff-Last E
    Hamostaseologie; 2007 Feb; 27(1):22-31. PubMed ID: 17279273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is screening for thrombophilia cost-effective?
    Wu O; Greer IA
    Curr Opin Hematol; 2007 Sep; 14(5):500-3. PubMed ID: 17934357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.